Triple
T9807402
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | programmed death-ligand 1 |
E238185
|
entity |
| Predicate | targetOfDrug |
P37016
|
FINISHED |
| Object |
avelumab
Avelumab is a human monoclonal antibody immunotherapy drug used to treat certain cancers by blocking the PD-L1 immune checkpoint pathway.
|
E822413
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69ca84defac48190abc1148804f184c1 |
elicitation | completed |
| NER | batch_69cdab7ddaac8190a5584a5c863fbaa3 |
ner | completed |
| NED1 | batch_69d1cc57119881909616d835def02fc9 |
ned_source_triple | completed |
| NED2 | batch_69d1cd8fcf488190bc72a99e81fb618b |
ned_description | completed |
| NEDg | batch_69d1cd137b30819089356b9fbc265d17 |
nedg | completed |
Created at: March 30, 2026, 8:29 p.m.